Having studied the biological effects (actually lack thereof-no fibrosis or neoplasia) after long term (10 mg/m3 for 6 h a day, 5 days a week for 12 months plus 12 months observation, or for a full 24 months) inhalation exposure of wollastonite in rats (McConnell et al, 1991) , I was surprised to find the authors of this article reporting pulmonary fibrosis after intratracheal (IT) instillation. I offer the following comments and possible explanation for this unexpected result.
It is difficult to determine from the report what their rats were actually exposed to or the total exposure. The authors reported that they obtained their wollastonite sample by "mechanical treatment (crushing, sedimentation, etc)" and reported a geometric mean length x diameter of 1 1-57 x 1-34 aum (wollastonite-China) and 9-22 x 1-21 (wollastonite-NYCO). Although this size of fibres could clearly reach the alveolar region of the lung through inhalation, the authors do not report what else was present in the sample injected into the lung-such as, the number, size, and other characteristics of the non-fibrous particulates that would also be produced by "crushing" and would also be injected into the lung. Was any effort made to clean up the sample of wollastonite so that only particulates of relevant size were injected? Most of a crushed sample would not be in an aerosol and all of those particulates >1-5 ,im diameter in the aerosol would be filtered by the nose and upper airways and never reach the alveolar region. Also, although the authors report that each instillation contained "about 3 x 109 particles sample" and that the "Exposure lasted three months", it is impossible to determine the number of exposures-that is, 1, 2, or 3 instillations a week? for 1, 2, 3, weeks, or for the full 3 months?
Notwithstanding the lack of adequate description of the protocol, I 
